TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jonel Pasula Reumatolog AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 3 | 4 | 1 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 2 | -1 | -2 |
EBITDA | 1 | -2 | -2 |
Total assets | 68 | 83 | 107 |
Current assets | 68 | 83 | 107 |
Current liabilities | 43 | 45 | 64 |
Equity capital | 24 | 36 | 41 |
- share capital | 9 | 9 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 35.3% | 43.4% | 38.3% |
Turnover per employee | 3 | 4 | 1 |
Profit as a percentage of turnover | 66.7% | -25.0% | -200% |
Return on assets (ROA) | 2.9% | -1.2% | -1.9% |
Current ratio | 158.1% | 184.4% | 167.2% |
Return on equity (ROE) | 8.3% | -2.8% | -4.9% |
Change turnover | -1 | 3 | -2 |
Change turnover % | -27% | 193% | -61% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.